Medtronic gains rights to Angeion ICD patents through arbitrator's decision; Angeion considers legal action.
This article was originally published in The Gray Sheet
Executive Summary
ANGEION WEIGHS RESPONSE TO AWARDING OF ICD PATENTS TO MEDTRONIC by arbitrator William Webster of the Washington D.C. law firm Milbank, Tweed, Hadley & McCloy. Webster's decision resolves a patent licensing dispute brought by Pacesetter parent St. Jude against Medtronic in 1995. Pacesetter obtained rights to Angeion's implantable cardioverter defibrillator patents in 1993 ("The Gray Sheet" March 22, 1993, In Brief).
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.